Showing results (91-100 of 122) with videos related to
Sort By:
Pageof 13
European Journal of Medical Research|June 18, 2010
Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in GermanyEva Wolf, M Blankenburg, J R Bogner, et al.Journal of Medicinal Chemistry|December 10, 2025
Nanoscale Direct-to-Biology Optimization and Structural Insights into Selective S. aureus TrmD InhibitorsAriane F Hübner, Annabelle C Weldert, Tessa Marciniak, et al.AIDS Research and Therapy|September 9, 2021
Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistanceEva Wolf, Christoph Boesecke, Annamaria Balogh, et al.Nature Communications|October 31, 2023
A marine cryptochrome with an inverse photo-oligomerization mechanismHong Ha Vu, Heide Behrmann, Maja Hanić, et al.Vaccine|October 23, 2013
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled studyThomas Harrer, Andreas Plettenberg, Keikawus Arastéh, et al.Journal of the International Association of Providers of AIDS Care|April 11, 2017
Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort StudySebastian Noe, Silke Heldwein, Rita Pascucchi, et al.Antioxidants & Redox Signaling|January 28, 2022
Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air PollutionAndreas Daiber, Katie Frenis, Marin Kuntic, et al.Communications Biology|October 22, 2020
IM30 IDPs form a membrane-protective carpet upon super-complex disassemblyBenedikt Junglas, Roberto Orru, Amelie Axt, et al.BMC Biology|February 1, 2011
The activation mechanism of Irga6, an interferon-inducible GTPase contributing to mouse resistance against Toxoplasma gondiiNikolaus Pawlowski, Aliaksandr Khaminets, Julia P Hunn, et al.Journal of Clinical Microbiology|August 3, 2018
Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference AssayFrank Wiesmann, Robert Ehret, Gudrun Naeth, et al.Pageof 13